Skip to Content

New Non-Chemotherapy Drug

A Phase II Trial of Ofatumumab in Previously Untreated Follicular NHL

Objective

Many patients will have their lymphoma come back after chemotherapy. This study is looking at a new agent to see if it works better than chemotherapy.

IRB Protocol Number
CALGB 50901
Principal Investigator(s)
Charles Catcher, MD

Clinical Trial Categories

  • Lymphoma/Lymph Node/Leukemia/Blood-related Cancers
Sponsor(s)
National Cancer Institute
Contact
Margaret White, RN OCN, CC at 603-232-8908
How to Participate

Inclusion Criteria:

  • Must be able to see the cancer on a scan;
  • Must have a sample of bone marrow removed to enroll in the study;
  • Patients who have never had treatmetn for lymphoma.

Exclusion Criteria:

  • Must be off steroids 2 weeks before enrollment.

 

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000